Evidence mapPaperPMID 35626276Full record

ArticleDiagnostics (Basel, Switzerland)2022

Analytical Validation of GFR

Markus Fuhrmann, Amauri Schwaeble Santamaria, Renee Scott, Jeffrey W Meeusen, Marianna Fernandes, John Venz, Victoria Rothe, Frank Stämmler, Jochen Ehrich, Eric Schiffer

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Markus FuhrmannDepartment of Research and Development, numares AG, 93053 Regensburg, Germany.
Amauri Schwaeble SantamariaDepartment of Research and Development, numares AG, 93053 Regensburg, Germany.
Renee ScottDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Jeffrey W MeeusenDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Marianna FernandesBoston Heart Diagnostics, Framingham, MA 01702, USA.
John VenzDepartment of Research and Development, numares AG, 93053 Regensburg, Germany.
Victoria RotheDepartment of Research and Development, numares AG, 93053 Regensburg, Germany.
Frank StämmlerDepartment of Research and Development, numares AG, 93053 Regensburg, Germany.ORCID 0000-0003-2841-0610
Jochen EhrichChildren's Hospital, Hannover Medical School, 30625 Hannover, Germany.
Eric SchifferDepartment of Research and Development, numares AG, 93053 Regensburg, Germany.
Mayo Clinic · USMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate and precise monitoring of kidney function is critical for a timely and reliable diagnosis of chronic kidney disease (CKD). The determination of kidney function usually involves the estimation of the glomerular filtration rate (eGFR). We recently reported the clinical performance of a new eGFR equation (GFR

Indexed as

analytical validationeGFRglomerular filtration rateinterferencelinearitymetaboliteNMRprecisionstabilitytrueness

Identifiers

PMID35626276
PMCPMC9139323
OpenAlexW4225130393

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.